Article
Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective.
Expert review of pharmacoeconomics & outcomes research - 1 Sept 2022
de Alava Enrique, Pareja María Jesús, Carcedo David, Arrabal Natalia, García José-Francisco, Bernabé-Caro Reyes
Abstract excerpt
BACKGROUND: To assess the cost-effectiveness of using next-generation sequencing (NGS) compared to sequential single-testing (SST) for molecular diagnostic and treatment of patients with advanced non-small cell lung cancer (NSCLC) from a Spanish single-center perspective, the Hospital Universitario Virgen del Rocio (HUVR). RESEARCH DESIGN AND METHODS: A decision-tree model was developed to assess the alterations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.